| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 10/04/2007 | WO2007110727A2 Amide stabilized hydroxyethylamines |
| 10/04/2007 | WO2007110364A1 Benzothiazoles having histamine h3 receptor activity |
| 10/04/2007 | US20070232654 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 10/04/2007 | US20070232620 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents |
| 10/04/2007 | US20070232606 Compounds and Compositions as Cathepsin S Inhibitors |
| 10/04/2007 | US20070232601 Vla-4 Inhibitor |
| 10/04/2007 | US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof |
| 10/04/2007 | US20070231839 N-(3-oxododecanoyl)-L-homoserine lactone, binding to carrier; used as vaccine or to raise and subsequently isolate antibodies or binding portions thereof which are capable of recognizing and binding to the autoinducer; carrier molecule comprises a lysine-containing protein, such as bovine serum albumin |
| 10/04/2007 | CA2681639A1 Compounds and methods for treatment of disorders associated with er stress |
| 10/04/2007 | CA2647603A1 Ureide derivative and use thereof for medical purposes |
| 10/04/2007 | CA2645639A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 10/04/2007 | CA2645581A1 Benzothiazoles having histamine h3 receptor activity |
| 10/03/2007 | EP1838682A2 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them |
| 10/03/2007 | EP1838655A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 10/03/2007 | EP1737850B1 A novel process for the preparation of linezolid and related compounds |
| 10/03/2007 | EP1611083B1 Synthesis of 2-chloromethyl-6-methylbenzoic acid esters |
| 10/03/2007 | EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 10/03/2007 | EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 10/03/2007 | EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases |
| 10/03/2007 | CN101045713A Synthesis method of phenethyl oxazolidine 2,4-diketone |
| 10/03/2007 | CN100340562C Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | US7276526 Comprising a cyclopropyl, and aryl or heteroaryl substitutions; treating neurological and psychological disorders |
| 09/27/2007 | WO2007107311A2 Organic sulphinic acid derivatives |
| 09/27/2007 | US20070225505 Method for the Preparation of (2S, 3AR, 7AS)-Octahydro-III-Indole-2-Carboxylic Acid as Key Intermediate in the Preparation of Trandolapril by Reacting a Cyclohexyl Aziridine with a Dialkyl Malonate |
| 09/27/2007 | US20070225499 Process for the Preparation of 2,2-Disubstituted Pyrroles |
| 09/27/2007 | US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 09/27/2007 | US20070225294 2-[4-({[4-{[4-(4-acetylphenyl)-1-piperazinyl]methyl}-2-(4-fluorophenyl)-1,3-thiazol-5-yl]methyl}sulfanyl)-2-methylphenoxy]-2-methylpropanoic acid; dyslipidemia, syndrome X, hypercholesteremia, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, and obesity |
| 09/26/2007 | EP1836177A2 Vitamin d receptor modulators |
| 09/26/2007 | EP1836173A2 Anti-inflammatory medicaments |
| 09/26/2007 | EP1836158A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 09/26/2007 | EP1836150A1 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 09/26/2007 | EP1836149A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 09/26/2007 | EP1699752B1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/26/2007 | EP1380121B1 Process to prepare oxazolidinones |
| 09/26/2007 | EP1341753B1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 09/26/2007 | CN101044126A Prodrug substituted benzoxazoles as estrogenic agents |
| 09/26/2007 | CN101041643A Synthesis of 4-(4- nitrobenzene radical) oxazole |
| 09/26/2007 | CN100339360C Process for producing aromatic nitrile compound |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/20/2007 | WO2007106818A1 Synthesis of pentafluorosulfanyl (sf5)-substituted heterocycles and alkynes |
| 09/20/2007 | WO2007104144A1 Compounds, ionic liquids, molten salts and uses thereof |
| 09/20/2007 | US20070219395 2-(3-Hydroxyphenoxymethyl)-6-methylbenzoic Acid as chemical intermediate for synthesizing PPAR agonists and antagonists |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors |
| 09/20/2007 | CA2646223A1 Novel heterocyclic nf-kb inhibitors |
| 09/19/2007 | EP1833805A1 New 3-phenylpropionic acid derivatives for the treatment of diabetes |
| 09/19/2007 | EP1833796A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 09/19/2007 | EP1511719B1 Amide derivatives as inhibitors of the enzymatic activity of renin |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338040C Xanthine oxidase inhibitors |
| 09/18/2007 | US7271169 1,4-disubstituted piperazine compounds; for example 2-{4-[2-(acetylamino)-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-(3-phenylphenyl)acetamide; cardiovascular diseases such as arrhythmias, intermittent claudication, angina, congestive heart disease, diabetes, and myocardial infarction |
| 09/13/2007 | WO2006122216A3 Processes for production of phenolic 4-biphenylylazetidin-2-ones |
| 09/13/2007 | US20070213377 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators |
| 09/13/2007 | US20070213348 Chemical Compounds |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/12/2007 | EP1831145A1 Substituted oxyarenes |
| 09/12/2007 | EP1519925B1 Oxazole derivatives and their use as insulin sensitizers |
| 09/12/2007 | EP1030850B1 Azoline derivatives |
| 09/12/2007 | EP1019358B2 3,3-diarylpropylamines , their use and preparation |
| 09/12/2007 | CN101035776A Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 09/12/2007 | CN101033216A Oxazolidine compound for synthesizing taxone pharmaceutical side-chain and preparation method thereof |
| 09/11/2007 | US7268135 Biaryl sulfonamides and methods for using same |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7267925 Photosensitive composition and novel compound used therefor |
| 09/11/2007 | CA2442219C Enantioselective synthesis of azetidinone intermediate compounds |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2231975C Substituted amino compounds and their use as substances having an analgesic effect |
| 09/11/2007 | CA2163175C Anti-viral aromatic o-alkylated oximes, ethers and thioethers |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/06/2007 | US20070208185 Intermediates for the hemisynthesis of taxanes and preparation processes therefor |
| 09/06/2007 | US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208069 Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 09/06/2007 | US20070208066 ER-beta-selective ligands |
| 09/06/2007 | US20070208065 Such as 5-[4-(1,1-dimethylethyl)phenyl]-N-hydroxy-4-phenyl-2-oxazolchexanamide which inhibits production of IL-6 and/or TNF alpha by inflammatory cytokines; inflammatory diseases, autoimmune diseases |
| 09/06/2007 | US20070208055 Alternative synthesis of renin inhibitors and intermediates thereof |
| 09/06/2007 | US20070208021 Phenoxyacetic Acid Derivatives and Drug Comprising The Same |
| 09/05/2007 | EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof |
| 09/05/2007 | EP1828177A2 Novel mch receptor antagonists |
| 09/05/2007 | EP1828154A1 Phenyl-piperazin methanone derivatives |
| 09/05/2007 | EP1828149A1 Method for the production of oxazoles by condensing aromatic aldehydes with a-ketoximes to n-oxides and then reacting the same with activated acid derivatives |
| 09/05/2007 | EP1827427A1 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 09/05/2007 | EP1368334B1 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 09/05/2007 | CN101031553A 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (ppar) ligands for the treatment of hyperlipidemia and diabetes |
| 09/05/2007 | CN101031552A Photoactive 4,4-disubstituted oxazolidine derivative and its manufacturing method |
| 09/05/2007 | CN101031540A 六氟异丙醇取代的醚衍生物 Hexafluoroisopropanol substituted ether derivatives of |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029033A Production of N-contained pentabasic heteroaromatic dimethyl ether |
| 09/04/2007 | US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses |
| 09/04/2007 | US7265140 E.g., ({[Acetyl({(5R)-3-[4-(1,1-dioxidotetrahydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}-methyl)amino]carbonyl}oxymethyl acetate; these compounds have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria |
| 09/04/2007 | US7265138 inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 09/04/2007 | US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |